The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas

Glioblastoma multiforme is the most common primary brain tumor and among the most lethal types of cancer. Several mono-target small molecule-inhibitors have been investigated as novel therapeutics, thus far with poor success. In this study we investigated the anticancer effects of SB747651A, a multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Arnon Møldrup, Boldt, Henning Bünsow, Jakobsen, Elisabeth Victoria, Kristensen, Bjarne Winther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966768/
https://www.ncbi.nlm.nih.gov/pubmed/33727611
http://dx.doi.org/10.1038/s41598-021-85536-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966768/
https://www.ncbi.nlm.nih.gov/pubmed/33727611
http://dx.doi.org/10.1038/s41598-021-85536-4

Ejemplares similares